DB-1202
- Generic Name
- DB-1202
A Study of DB-1202 Monotherapy in Advanced Solid Tumors
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- DualityBio Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05785728
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath